FindMyKOL

Nelson Watts, MD

Basic profile

Mercy Health

ORCIDOn fileNPIOn fileSign in to see identifiers
✓ Itemized record
RegionCincinnati, OH · MidwestSpecialtyEndocrinology, Diabetes & MetabolismFocusEndocrinology/Metabolic
Active KOLFindMyKOL type: RegionalLatest publicationSee ScholarshipOnline presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Nelson Watts is an Endocrinology/Metabolic physician affiliated with Mercy Health. OpenAlex indexes 379 publications with 33,732 citations (h-index 86). By OpenAlex citation count, this profile ranks in the top 5% of Endocrinology, Diabetes & Metabolism profiles in the FindMyKOL directory.

Overview

Scholarship

indexed output and impact (OpenAlex)
379publications

Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.

33,732citations

Citations across these publications.

86h-index

H-index from these publications.

Clinical & industry

trials, payments and federal funding
29companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Industry payments

29 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

  • Amgen Inc.
    Program year202510 payments
    $336
  • Tandem Diabetes Care, Inc.
    Program year20257 payments
    $251
  • Insulet Corporation
    Program year20253 payments
    $60
All 58 payment records: search, sort and filter.Explore →

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Musculoskeletal

    98.9%
    RANK Ligand Inhibitor98.8%
    Denosumab100%Prolia0%
    Part D + Part B≥421 patients
    Bisphosphonates0%
    Risedronate Sodium100%
    Part D<11 patients
  • Cardiovascular

    0.6%
    Thiazide diuretic0.4%
    Hydrochlorothiazide100%
    Part D≥57 patients
    Thiazide-like diuretic0.1%
    Indapamide100%
    Part D≥14 patients

    + 1 more class in this area

  • Metabolism & gastrointestinal

    0.3%
    Vitamin D3 Analog0.3%
    Calcitriol100%
    Part D≥35 patients
    Metabolic Alkalinizer0%
    Potassium Citrate Er100%
    Part D<11 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”